What’s the deal with peptide purity and testing? How do I know what I’m actually getting?

A certificate of analysis, or COA, reports results for a tested sample. Useful information includes the laboratory, test date, sample and batch identifiers, analytical methods, actual results, and acceptance limits. “Third-party tested” is less informative when the report cannot be authenticated or linked to the batch supplied. Independent testing helps, but it does not establish that the sample submitted represents every vial sold.[1]

Chromatography, often HPLC, can separate a peptide from certain impurities; mass spectrometry can help establish molecular identity. A reported chromatographic purity of 99% is not automatically proof that a vial contains the labeled milligrams. Quantity needs an appropriate calibrated measurement, and different analytical methods detect different problems. Sterility, bacterial endotoxins, and particles are additional concerns for injectable products, not facts established by a single purity percentage.[2][3]

Practical scrutiny means checking whether the lot numbers match, confirming the report directly with the named laboratory when possible, and distinguishing identity testing from content and microbiological testing. Even a credible COA does not establish clinical effectiveness, long-term safety, or FDA approval. A verified pharmaceutical supply chain provides controls beyond a vendor’s posted PDF; a purity certificate cannot make a research reagent equivalent to an approved medicine.[1][3]